METHOD OF PRODUCING A RECOMBINANT PROTEIN
Provided herein are methods of producing a recombinant protein that include fed-batch culturing a mammalian cell.
1 . A method of producing a recombinant protein, the method comprising:
(a) providing a cell culture comprising a CHO cell in a liquid culture medium, wherein the CHO cell comprises a nucleic acid encoding a recombinant protein, wherein the cell culture has a volume;
(b) fed-batch culturing the cell culture of step (a) under conditions sufficient for the CHO cell to produce the recombinant protein, wherein:
the fed-batch culturing comprises adding a volume of a first feed culture medium comprising 0.8× to 1.0× BalanCD™ CHO Feed 4 on about day 2 to about day 5 of the culture and adding a volume of a second feed culture medium comprising 0.9× to 1.1× BalanCD™ CHO Feed 2 on about day 6 to about day 13; and
(c) recovering the recombinant protein from the CHO cell or the liquid culture medium.
2 . The method of claim 1 , wherein one or more of the liquid culture medium, the first feed culture medium, and the second feed culture medium further comprise(s) a concentration of N-acetylglucosamine sufficient to maintain a concentration of N-acetylglucosamine in the cell culture of about 2 mM to about 8 mM relative to the volume of the cell culture in step (a).
3 . The method of claim 1 , wherein the fed-batch culturing further comprises adding a volume of a supplement comprising a concentration of N-acetylglucosamine sufficient to maintain a concentration of N-acetylglucosamine in the cell culture of about 2 mM to about 8 mM.
4 . The method of any one of claims 1 - 3 , wherein the volume of the first feed culture medium added on about day 2 to about day 5 is about 4% to about 10% of the volume of the cell culture in step (a) per day.
5 . The method of claim 4 , wherein the volume of the first feed culture medium added on about day 2 to about day 5 is about 5% of the volume of the cell culture in step (a) per day.
6 . The method of any one of claims 1 - 5 , wherein the volume of the second feed culture medium added on about day 6 to about day 13 is about 4% to about 10% of the volume of the cell culture in step (a) per day.
7 . The method of claim 6 , wherein the volume of the second feed culture medium added on about day 6 to about day 13 is about 5% to about 7% of the volume of the cell culture in step (a) per day.
8 . The method of any one of claims 1 - 7 , wherein the first feed culture medium comprises about 0.8× BalanCD CHO Feed 4.
9 . The method of any one of claims 1 - 8 , wherein the second feed culture medium comprises about 1.0× BalanCD™ CHO Feed 2.
10 . The method of any one of claims 1 - 9 , wherein the fed-batch culturing further comprises adjusting the temperature of the culture on about day 7 to about day 8.
11 . The method of claim 10 , wherein the temperature of the culture is adjusted from a first temperature of about 35-38° C. to a second temperature of about 28-34.9° C.
12 . The method of claim 10 , wherein the temperature of the culture is adjusted from a first temperature of about 36.5° C. to a second temperature of about 34° C.
13 . The method of any one of claims 1 - 12 , wherein the fed-batch culturing further comprises maintaining the pH of the cell culture at about 6.7 to about 7.1.
14 . The method of claim 13 , wherein upon the cell culture obtains a pH of 6.9, the pH is maintained at about 6.88 to about 6.92.
15 . The method of any one of claims 1 - 14 , wherein the fed-batch culturing further comprises maintaining the dO 2 of 40%.
16 . The method of any one of claims 1 - 15 , wherein the fed-batch culturing further comprises agitating the cell culture at about 10 RPM to about 500 RPM.
17 . The method of claim 16 , wherein the fed-batch culturing further comprises agitating the cell culture at about 180 RPM to about 220 RPM.
18 . The method of any one of claims 1 - 15 , wherein the fed-batch culturing further comprises agitating the cell culture using an impeller tip speed of 0.4 m/s to about 4.0 m/s.
19 . The method of any one of claims 1 - 15 , wherein the fed-batch culturing further comprises agitating the cell culture using an impeller power consumption per volume of about 10 W/m 3 to about 35 W/m 3 .
20 . The method of any one of any one of claims 1 - 19 , wherein the recovering in step (c) occurs on day 14.
21 . The method of any one of claims 1 - 19 , wherein the cell culture has a percent of cell viability and wherein the recovering in step (c) occurs when the percent of cell viability falls below a value selected from the group consisting of about 70%, about 60%, about 50%, about 40%, and about 30%.
22 . The method of any one of claims 1 - 21 , wherein the CHO cell is a DG44 cell.
23 . The method of any one of claims 1 - 22 , wherein the first feed culture medium and the second feed culture medium further comprises about 4 g/L glucose to about 6 g/L glucose.
24 . The method of claim 23 , wherein the first feed culture medium and the second feed culture medium comprises about 5 g/L glucose.
25 . The method of any one of claims 1 - 24 , wherein the recombinant protein is a fusion protein, antibody, or antibody fragment.
26 . The method of any one of claims 1 - 25 , further comprising:
generating the cell culture of step (a) comprising inoculating the liquid culture medium with a population of the CHO cells.
27 . The method of claim 26 , wherein the population of the CHO cells has not been previously cultured in the liquid culture medium.
28 . The method of any one of claims 1 - 27 , wherein the liquid culture medium is HyClone™ ActiPro™.
29 . The method of any one of claims 1 - 27 , wherein the liquid culture medium is CD-C4.
30 . The method of any one of claims 1 - 29 , further comprising:
purifying the recovered recombinant protein.
31 . The method of claim 30 , further comprising:
formulating the purified recombinant protein into a pharmaceutical composition.
32 . A recombinant protein produced by the method of any one of claims 1 - 31 .
33 . A pharmaceutical composition produced by the method of claim 31 .
34 . A method of treating a subject in need thereof comprising administering to the subject a therapeutically effective amount of the recombinant protein of claim 32 or the pharmaceutical composition of claim 33 .